Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Plumpy'Doz is a ready-to-use supplementary food (RUSF) designed specifically for the prevention of moderate acute malnutrition (MAM) in children aged 6 to 59 months. Developed by Nutriset, it is a lipid-based nutrient supplement (LNS) that provides a balanced mix of macronutrients (fats, proteins, carbohydrates) and essential micronutrients (vitamins and minerals) to complement breastfeeding and local diets. Unlike therapeutic foods used for treatment, Plumpy'Doz is intended as a preventive measure during periods of high nutritional risk, such as lean seasons or food crises. Its mechanism of action involves addressing nutritional gaps to support healthy growth, immune function, and cognitive development, thereby reducing the incidence of wasting and stunting in vulnerable populations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Plumpy'Doz.